Tiziana Life Sciences (TLSA) Enterprise Value Growth (1y) (2018 - 2025)
Tiziana Life Sciences (TLSA) Enterprise Value Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn |
| 10 | Tiziana Life Sciences | 110.93 Mn | 106.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.68% |
| Jun 30, 2025 | -1,693.63% |
| Dec 31, 2024 | -376.82% |
| Jun 30, 2024 | 106.81% |
| Dec 31, 2023 | 95.89% |
| Jun 30, 2023 | 74.84% |
| Dec 31, 2022 | 54.98% |
| Jun 30, 2022 | 50.81% |
| Dec 31, 2021 | 33.74% |
| Jun 30, 2021 | -503.56% |
| Dec 31, 2020 | -32,265.55% |
| Jun 30, 2020 | -1,461.86% |
| Dec 31, 2019 | 96.33% |
| Jun 30, 2019 | -536.61% |
| Dec 31, 2018 | -8,309.79% |